Target intelligence / Profile preview

Mycobacterial ATP synthase c subunit (AtpE)

Target
AtpE
Molecular classification
Enzyme, ATP synthase subunit (Rotor subunit), Ion transporter (proton translocator)
01

Overview

The mycobacterial ATP synthase c subunit (AtpE) is a membrane-embedded component of the ATP synthase enzyme complex, essential for the synthesis of ATP by oxidative phosphorylation in mycobacteria such as Mycobacterium tuberculosis. The c subunit forms an oligomeric ring (typically composed of nine c-subunits in mycobacteria) that acts as a proton-translocating rotor; as protons move through the ring, this drives the rotational catalysis needed for ATP generation[1][3][9]. The c subunit is the direct molecular target of diarylquinoline antimycobacterial drugs like bedaquiline, which bind to the c-ring and block proton translocation, leading to inhibition of ATP synthesis and mycobacterial cell death[5][8]. This therapeutic targeting represents a novel and critical approach in tuberculosis pharmacotherapy, particularly for drug-resistant forms of the disease. Resistance can arise via mutations in atpE, the gene encoding the c subunit[8]. Human ATP synthase is significantly less sensitive to these inhibitors, supporting the therapeutic specificity of targeting mycobacterial AtpE[5].

Other names
ATP synthase subunit cAtpE
02

Mechanism of action

Inhibition of proton translocation through the c-ring; Stalling of ATP synthesis through binding and blocking ion-conducting sites; Uncoupling of the proton-motive force in mycobacterial membranes

03

Biological functions

ATP synthesisOxidative phosphorylationCellular energy metabolism
04

Disease associations

InfectionTuberculosis
05

Safety considerations

Potential for development of resistance through atpE mutations[8]Off-target effects in non-mycobacterial ATP synthases appear low but should be monitored[5]
06

Interacting drugs

Bedaquiline (TMC207)

4 more in the full profile.

07

Biomarkers

Mutations in AtpE associated with bedaquiline resistance may serve as efficacy biomarkers[8]

Beyond the preview

Go deeper on Mycobacterial ATP synthase c subunit (AtpE).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mycobacterial ATP synthase c subunit (AtpE).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call